CME Group stock barely budged on Thursday, edging up just 0.2% to about US$295 after the Q3 2026 release. For a company that clears risk for the world, that is a surprisingly calm reaction to a very strong volume and margin story. Quarterly revenue came in at US$1.74b with adjusted earnings per share at US$3.02, powered by record futures activity and a 69.4% adjusted operating margin.
Short term traders saw a quiet tape. Long term holders watched a high margin, high volume engine reinforce why this derivatives company often trades at a premium multiple.
Like CME Group's margin profile but want more than a single ticker in your playbook? Explore a broader set of resilient derivatives and financial infrastructure plays in our list of solid balance sheet and fundamentals stocks (25 results).
Earnings tell you how Q3 looked on paper, but investors who care about what they are paying for CME Group often focus on the cash that actually comes through the door.
If you look at CME Group's cash flows in isolation, the stock could be a meaningful 20% overvalued.
Optimists argue CME Group can turn fresh products and tech into a bigger, stickier futures franchise. The key claim is clear.
"The main thing that has to go right is that CME Group continues to extend its product set and technology, including tokenized cash, a potential stablecoin, and new contracts across asset classes, while defending its position against competitors in rates, energy, and perpetual futures."
Record Q3 average daily volume of 29.4 million contracts and double digit gains in all six asset classes suggest the extension piece is working. New launches in compute futures, single stock contracts, crypto and sports indices show follow through. Margin savings above US$100b a day and progress on CME Securities Clearing back up the tech and capital efficiency push.
The worry is that rivals erode CME Group’s benchmarks or that new tech rails slip, turning today’s strengths into tomorrow’s drag.
"Sell side concerns about competition in key asset classes, including comments that other exchanges are gaining share in energy and that a rival is a threat in rates, could lead investors to reassess CME Group’s ability to sustain its role in benchmark contracts, which may pressure revenue growth and put CME’s earnings and net margins under scrutiny."
Energy and rates concerns bump up against record Henry Hub gas open interest and heavy Treasuries and FedWatch driven activity. At the same time, the pulled 24/7 small WTI filing and CFTC dispute over bitcoin perpetuals show that regulatory friction and product recalibration are real, even if Q3 revenue and the 69.4% adjusted operating margin do not yet show clear competitive damage.
One Narrative disagrees with today's price. → See where this Narrative says CME Group should trade.
CME Group just reported a strong quarter and the share price has barely moved. The real opportunity is spotting stocks that could be undervalued before the market closes that gap.
That is three of the list. See the full list of 33 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com